HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary R Lichtenstein Selected Research

Infliximab (Remicade)

12/2021Supratherapeutic Infliximab Levels Do Not Predict Risk of Short-term Complications in Adults With Crohn's Disease.
1/2019Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab.
11/2018Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.
3/2018Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017.
1/2018Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience.
12/2014Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.
2/2014Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
1/2014Treatment of ulcerative colitis.
11/2013Impact of JC virus antibody testing in patients with Crohn's disease with loss of response to infliximab: a Markov model.
9/2012Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary R Lichtenstein Research Topics

Disease

63Crohn Disease (Crohn's Disease)
12/2021 - 04/2002
54Ulcerative Colitis
01/2021 - 10/2002
52Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2022 - 10/2002
12Infections
01/2021 - 08/2003
7Neoplasms (Cancer)
01/2021 - 10/2009
7Rheumatoid Arthritis
01/2021 - 05/2002
4Colitis
08/2021 - 09/2006
4Necrosis
01/2019 - 01/2005
4Diarrhea
01/2018 - 04/2005
4Hemorrhage
04/2016 - 12/2005
4Inflammation (Inflammations)
10/2011 - 04/2005
4Colorectal Neoplasms (Colorectal Cancer)
02/2010 - 10/2005
4Fistula
07/2008 - 06/2004
3Skin Neoplasms (Skin Cancer)
01/2021 - 11/2014
3Lymphoma (Lymphomas)
05/2015 - 09/2011
3Tuberculosis (Tuberculoses)
09/2011 - 09/2007
3Pouchitis
06/2007 - 03/2006
2Pulmonary Embolism
01/2021 - 01/2018
2Pain (Aches)
01/2021 - 01/2020
2Psoriatic Arthritis
01/2021 - 01/2019
2Ankylosing Spondylitis
01/2019 - 03/2018
2Spontaneous Abortion (Miscarriage)
11/2018 - 12/2004
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
07/2018 - 06/2007
2Diabetes Mellitus
10/2017 - 10/2011
2Progressive Multifocal Leukoencephalopathy
11/2013 - 11/2012
2Chronic Hepatitis C
04/2013 - 12/2005
2Ulcer
04/2012 - 03/2006
2Adenoma (Adenomas)
01/2008 - 07/2002
2Hepatic Encephalopathy
06/2007 - 03/2006
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2007 - 12/2005
2Gastritis
06/2007 - 04/2005
2Pathologic Constriction (Stenosis)
05/2006 - 06/2005
1Hepatocellular Carcinoma (Hepatoma)
11/2021
1Opportunistic Infections (Opportunistic Infection)
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Arthritis (Polyarthritis)
01/2021
1Herpes Zoster
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
11/2018
1Stroke (Strokes)
01/2018
1Abdominal Pain (Pain, Abdominal)
01/2018
1Latent Tuberculosis
12/2017

Drug/Important Bio-Agent (IBA)

46Infliximab (Remicade)FDA Link
12/2021 - 05/2002
19Adrenal Cortex Hormones (Corticosteroids)IBA
07/2017 - 04/2002
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 10/2002
16Mesalamine (Mesalazine)FDA LinkGeneric
01/2019 - 01/2007
9Immunologic Factors (Immunomodulators)IBA
01/2017 - 08/2003
8Pharmaceutical PreparationsIBA
12/2021 - 03/2003
7Biological ProductsIBA
01/2021 - 01/2006
7acceleratory factor from growth hormone (AcG)IBA
08/2018 - 12/2010
7Sodium Glutamate (Accent)IBA
05/2006 - 05/2002
6Monoclonal AntibodiesIBA
01/2021 - 10/2002
6Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2019 - 08/2003
6SteroidsIBA
01/2019 - 07/2008
6Azathioprine (Imuran)FDA LinkGeneric
01/2019 - 08/2003
52-mercaptopurineIBA
01/2019 - 10/2010
5Adalimumab (Humira)FDA Link
03/2018 - 06/2007
5Phenobarbital (Luminal)FDA Link
04/2012 - 04/2005
4Biosimilar PharmaceuticalsIBA
01/2021 - 10/2017
4Budesonide (Pulmicort)FDA LinkGeneric
12/2017 - 09/2015
4CytokinesIBA
04/2006 - 10/2002
3tofacitinibIBA
01/2021 - 01/2021
3Janus Kinase InhibitorsIBA
01/2021 - 11/2018
3Opioid Analgesics (Opioids)IBA
01/2021 - 01/2020
3Biomarkers (Surrogate Marker)IBA
11/2018 - 01/2004
3AntibodiesIBA
03/2016 - 01/2011
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2014 - 09/2007
3Natalizumab (Tysabri)FDA Link
11/2013 - 09/2011
3Certolizumab PegolFDA Link
01/2012 - 07/2010
2Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 01/2019
2IntegrinsIBA
03/2018 - 09/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017 - 09/2006
2golimumabFDA Link
12/2014 - 01/2014
2Narcotics (Narcotic Analgesics)IBA
09/2012 - 05/2006
2Analgesics (Analgesic Drugs)IBA
09/2012 - 05/2006
2Prednisone (Sone)FDA LinkGeneric
09/2012 - 05/2006
2Immunoglobulin FragmentsIBA
08/2010 - 07/2010
2Rifaximin (L 105)FDA Link
06/2007 - 03/2006
2Anti-Bacterial Agents (Antibiotics)IBA
05/2005 - 08/2003
1COVID-19 VaccinesIBA
03/2022
1Immune Checkpoint InhibitorsIBA
08/2021
1omega-Chloroacetophenone (Mace)IBA
01/2021
1Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
01/2020
1GED0301IBA
01/2020
1Thioguanine (Tioguanine)FDA Link
01/2019
1Janus KinasesIBA
11/2018
1peficitinibIBA
11/2018
1Hemoglobins (Hemoglobin)IBA
11/2018
1ferric carboxymaltoseIBA
11/2018
1IronIBA
11/2018
1Interleukin-12 (IL 12)IBA
03/2018

Therapy/Procedure

61Therapeutics
01/2021 - 04/2002
8Biological Therapy
09/2021 - 04/2002
8Colectomy
01/2019 - 07/2002
6Remission Induction
07/2017 - 04/2002
2Chemoprevention
02/2008 - 09/2006
2Restorative Proctocolectomy
09/2006 - 06/2005
1Liver Transplantation
11/2021
1Ambulatory Care (Outpatient Care)
01/2021
1Length of Stay
01/2020